JNJ
Johnson & Johnson
stock NYSE

You’re being downvoted but you’re completely right. They are not like GILD where they have a strong monopoly like HIV. They have fierce competition from LLY and now potential Pfizer and JNJ if they also throw their hat in the ring

The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.
## 📉 **Oversold Stocks:**
Stocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [MSFT](https://marketrodeo.com/asset/MSFT) | Microsoft Corporation | 27.97 | 384.60 | -12.63 | -3.18% | $2.9T |
| [NFLX](https://marketrodeo.com/asset/NFLX) | Netflix, Inc. | 28.66 | 76.02 | -2.65 | -3.37% | $322.1B |
| [AXP](https://marketrodeo.com/asset/AXP) | American Express Company | 29.07 | 321.24 | -24.94 | -7.20% | $221.3B |
| [IBM](https://marketrodeo.com/asset/IBM) | International Business Machines Corporation | 22.97 | 223.35 | -33.81 | -13.15% | $208.8B |
| [NVO](https://marketrodeo.com/asset/NVO) | Novo Nordisk A/S | 26.84 | 39.63 | -7.79 | -16.43% | $176.2B |
Source: [Oversold](https://marketrodeo.com/screener?rsiLowerThan=30&exchange=NASDAQ%2CNYSE%2CAMEX)
## 📈 **Overbought Stocks:**
Stocks with RSI above 70, potentially indicating overbought conditions and possible downward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [AZN](https://marketrodeo.com/asset/AZN) | AstraZeneca PLC | 82.80 | 204.94 | +0.74 | +0.36% | $635.4B |
| [JNJ](https://marketrodeo.com/asset/JNJ) | Johnson & Johnson | 80.06 | 245.84 | +3.35 | +1.38% | $592.4B |
| [PG](https://marketrodeo.com/asset/PG) | The Procter & Gamble Company | 72.00 | 165.17 | +4.39 | +2.73% | $386.0B |
| [KO](https://marketrodeo.com/asset/KO) | The Coca-Cola Company | 72.05 | 80.56 | +0.72 | +0.90% | $346.5B |
| [NVS](https://marketrodeo.com/asset/NVS) | Novartis AG | 76.16 | 164.70 | +2.03 | +1.25% | $318.4B |
Source: [Overbought](https://marketrodeo.com/screener?rsiMoreThan=70&exchange=NASDAQ%2CNYSE%2CAMEX)
**Understanding RSI:**
- **RSI < 30:** Potentially oversold (stock may be undervalued)
- **RSI > 70:** Potentially overbought (stock may be overvalued)
- **RSI 30-70:** Normal trading range

Hey Jensen will you do anti-cancer nanobots in the future, or should I bet on MRK. JNJ or PFE instead?

Yeah I didn't expect these gains with WMT and JNJ

https://preview.redd.it/ema1fzdxfblg1.jpeg?width=528&format=pjpg&auto=webp&s=878f7053c348a01b1808202a10668c1afa7b8d55
“Now pump MRNA, MRK, JNJ, LLY, but not NVO”

They aren’t growth stocks, but my K, MO, and JNJ calls have been printing while the rest of my port bleeds.

JNJ.

JNJ

Kinda old news but JNJ is doing some expansion again in Pennsylvania.
https://www.jnj.com/media-center/press-releases/johnson-johnson-expands-u-s-footprint-with-more-than-1-billion-investment-in-next-generation-cell-therapy-manufacturing-facility-in-pennsylvania
The facility will use cutting-edge cell therapy technologies to support J&J's portfolio of medicines targeting cancer, immune-mediated diseases, and neurological conditions. It is expected to create over 500 skilled biomanufacturing jobs once operational and more than 4,000 construction jobs during development.
Seems like onshoring is still bullish and signals confidence in the oncology/immunology markets. No positions.

I held Pfizer for a long time and finally got rid of it without regret. I like JNJ, abbv, Lilly. Novartis. Merck.
I was in the industry for 30 years and I know it has changed but I am good with those positions for long term holds .

KO,PG,JNJ,MCD,PEP,CL,BLK,GS,JPM

The Oversold/Overbought list shows stocks that are trading at extreme levels based on their Relative Strength Index (RSI), suggesting potential short-term reversals during the trading session.
## 📉 **Oversold Stocks:**
Stocks with RSI below 30, potentially indicating oversold conditions and possible upward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [TMO](https://marketrodeo.com/asset/TMO) | Thermo Fisher Scientific Inc. | 29.38 | 510.93 | -4.19 | -0.81% | $192.0B |
| [CRM](https://marketrodeo.com/asset/CRM) | Salesforce, Inc. | 28.59 | 185.16 | -0.13 | -0.07% | $176.3B |
| [ACN](https://marketrodeo.com/asset/ACN) | Accenture plc | 28.83 | 215.35 | +0.40 | +0.19% | $133.5B |
| [BKNG](https://marketrodeo.com/asset/BKNG) | Booking Holdings Inc. | 24.98 | 4076.79 | +69.34 | +1.73% | $131.4B |
| [ADBE](https://marketrodeo.com/asset/ADBE) | Adobe Inc. | 29.51 | 258.61 | -0.60 | -0.23% | $108.3B |
Source: [Oversold](https://marketrodeo.com/screener?rsiLowerThan=30&exchange=NASDAQ%2CNYSE%2CAMEX)
## 📈 **Overbought Stocks:**
Stocks with RSI above 70, potentially indicating overbought conditions and possible downward reversals.
| Symbol | Company | RSI | Price | Change | %Change | Market Cap |
|:-------|:--------|:---:|:-----:|:------:|:-------:|:----------:|
| [AZN](https://marketrodeo.com/asset/AZN) | AstraZeneca PLC | 87.37 | 204.20 | -2.25 | -1.09% | $633.1B |
| [JNJ](https://marketrodeo.com/asset/JNJ) | Johnson & Johnson | 83.79 | 242.49 | -4.42 | -1.79% | $584.4B |
| [NVS](https://marketrodeo.com/asset/NVS) | Novartis AG | 75.26 | 162.67 | -1.25 | -0.76% | $314.5B |
| [MRK](https://marketrodeo.com/asset/MRK) | Merck & Co., Inc. | 70.35 | 122.26 | +0.40 | +0.33% | $305.4B |
| [LIN](https://marketrodeo.com/asset/LIN) | Linde plc | 73.59 | 496.51 | +6.40 | +1.31% | $231.8B |
Source: [Overbought](https://marketrodeo.com/screener?rsiMoreThan=70&exchange=NASDAQ%2CNYSE%2CAMEX)
**Understanding RSI:**
- **RSI < 30:** Potentially oversold (stock may be undervalued)
- **RSI > 70:** Potentially overbought (stock may be overvalued)
- **RSI 30-70:** Normal trading range

I have unh, lly, Nvo, nvs, abbv, jwel , cvs JNJ , MDT, ihi(etf), hhl(etf) I have found isrg to always be too expensive but da Vinci isn’t going away anytime soon